Safety and immunogenicity of the killed bivalent (O1 and O139) whole-cell cholera vaccine in the Philippines

References

• Ali M , Nelson AR , Lopez AL , Sack DA. Updated global burden of cholera in endemic countries. PLoS Negl Trop Dis. 2015;9:e0003832. doi:10.1371/journal.pntd.0003832. PMID:26043000
   PubMed Web of Science ®Google Scholar
• Deen JL , von Seidlein L , Sur D , Agtini M , Lucas ME , Lopez AL , Kim DR , Ali M , Clemens JD . The high burden of cholera in children: comparison of incidence from endemic areas in Asia and Africa. PLoS Negl Trop Dis. 2008;2:e173. doi:10.1371/journal.pntd.0000173. PMID:18299707
   PubMed Web of Science ®Google Scholar
• Lopez AL , Macasaet LY , Ylade M , Tayag EA , Ali M . Epidemiology of cholera in the Philippines. PLoS Negl Trop Dis. 2015;9:e3440. doi:10.1371/journal.pntd.0003440. PMID:25569505
   PubMed Web of Science ®Google Scholar
• Kanungo S , Paisley A , Lopez AL , Bhattacharya M , Manna B , Kim DR , Han SH , Attridge S , Carbis R , Rao R , et al. Immune responses following one and two doses of the reformulated, bivalent, killed, whole-cell, oral cholera vaccine among adults and children in Kolkata, India: a randomized, placebo-controlled trial. Vaccine. 2009;27:6887-93. doi:10.1016/j.vaccine.2009.09.008. PMID:19761838
   PubMed Web of Science ®Google Scholar
• Sur D , Kanungo S , Sah B , Manna B , Ali M , Paisley AM , Niyogi SK , Park JK , Sarkar B , Puri MK , et al. Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: results from 3 years of follow-up of a randomized, controlled trial. PLoS Negl Trop Dis. 2011;5:e1289. doi:10.1371/journal.pntd.0001289. PMID:22028938
   PubMed Web of Science ®Google Scholar
• Sur D , Lopez AL , Kanungo S , Paisley A , Manna B , Ali M , Niyogi SK , Park JK , Sarkar B , Puri MK , et al. Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial. Lancet. 2009;374:1694-702. doi:10.1016/S0140-6736(09)61297-6. PMID:19819004
   PubMed Web of Science ®Google Scholar
• Mahalanabis D , Lopez AL , Sur D , Deen J , Manna B , Kanungo S , Seidlein LV , Carbis R , Han SH , Shin SH , et al. A randomized, placebo-controlled trial of the bivalent killed, whole-cell, oral cholera vaccine in adults and children in a cholera endemic area in Kolkata, India. PLoS One. 2008;3:e2323. doi:10.1371/journal.pone.0002323. PMID:18523643
   PubMed Web of Science ®Google Scholar
• Bhattacharya SK , Sur D , Ali M , Kanungo S , You YA , Manna B , Sah B , Niyogi SK , Park JK , Sarkar B , et al. 5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial. Lancet Infect Dis. 2013;13:1050-6. doi:10.1016/S1473-3099(13)70273-1. PMID:24140390
   PubMed Web of Science ®Google Scholar
• Charles RC , Hilaire IJ , Mayo-Smith LM , Teng JE , Jerome JG , Franke MF , Saha A , Yu Y , Kováč P , Calderwood SB , et al. Immunogenicity of a killed bivalent (O1 and O139) whole cell oral cholera vaccine, Shanchol, in Haiti. PLoS Negl Trop Dis. 2014;8:e2828. doi:10.1371/journal.pntd.0002828. PMID:24786645
   PubMed Web of Science ®Google Scholar
• Severe K , Rouzier V , Anglade SB , Bertil C , Joseph P , Deroncelay A , Mabou MM , Wright PF , Guillaume FD , Pape JW . Effectiveness of Oral Cholera Vaccine in Haiti: 37-Month Follow-Up. Am J Trop Med Hyg. 2016;94:1136-42. doi:10.4269/ajtmh.15-0700. PMID:26928838
   PubMed Web of Science ®Google Scholar
• World Health Organization . Oral cholera vaccine stockpile for cholera emergency response. Available from: http://www.who.int/cholera/vaccines/Briefing_OCV_stockpile.pdf (Accessed 16 May 2015 ) 2013
   Google Scholar
• Saha A , Chowdhury MI , Khanam F , Bhuiyan MS , Chowdhury F , Khan AI , Khan IA , Clemens J , Ali M , Cravioto A , et al. Safety and immunogenicity study of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine Shanchol, in Bangladeshi adults and children as young as 1 year of age. Vaccine. 2011;29:8285-92. doi:10.1016/j.vaccine.2011.08.108. PMID:21907255
   PubMed Web of Science ®Google Scholar
• Kanungo S , Desai SN , Nandy RK , Bhattacharya MK , Kim DR , Sinha A , Mahapatra T , Yang JS , Lopez AL , Manna B , et al. Flexibility of oral cholera vaccine dosing-a randomized controlled trial measuring immune responses following alternative vaccination schedules in a cholera hyper-endemic zone. PLoS Negl Trop Dis. 2015;9:e0003574. doi:10.1371/journal.pntd.0003574. PMID:25764513
   PubMed Web of Science ®Google Scholar
• Desai SN , Akalu Z , Teshome S , Teferi M , Yamuah L , Kim DR , Yang JS , Hussein J , Park JY , Jang MS , et al. A randomized, Placebo-Controlled trial evaluating safety and immunogenicity of the killed, Bivalent, whole-cell oral cholera vaccine in Ethiopia. Am J Trop Med Hyg. 2015;93:527-33. doi:10.4269/ajtmh.14-0683. PMID:26078323
   PubMed Web of Science ®Google Scholar
• Concha A , Giraldo A , Castaneda E , Martinez M , de la Hoz F , Rivas F , Depetris A , Svennerholm AM , Sack DA . Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia. Bull Pan Am Health Organ. 1995;29:312-21. PMID:8605522
   PubMedGoogle Scholar
• Anh DD , Canh DG , Lopez AL , Thiem VD , Long PT , Son NH , Deen J , von Seidlein L , Carbis R , Han SH , et al. Safety and immunogenicity of a reformulated Vietnamese bivalent killed, whole-cell, oral cholera vaccine in adults. Vaccine. 2007;25:1149-55. doi:10.1016/j.vaccine.2006.09.049. PMID:17055622
   PubMed Web of Science ®Google Scholar
• Iyer AS , Bouhenia M , Rumunu J , Abubakar A , Gruninger RJ , Pita J , Lino RL , Deng LL , Wamala JF , Ryan ET , et al. Immune responses to an oral cholera vaccine in internally displaced persons in South Sudan. Sci Rep. 2016;6:35742. doi:10.1038/srep35742. PMID:27775046
   PubMed Web of Science ®Google Scholar
• Kossaczka Z , Shiloach J , Johnson V , Taylor DN , Finkelstein RA , Robbins JB , Szu SC . Vibrio cholerae O139 Conjugate Vaccines: synthesis and immunogenicity of V. cholerae O139 Capsular Polysaccharide conjugates with recombinant Diphtheria toxin mutant in mice. Infect Immunity. 2000;68:5037-43. doi:10.1128/IAI.68.9.5037-5043.2000. PMID:10948122
   PubMed Web of Science ®Google Scholar
• Losonsky GA , Lim Y , Motamedi P , Comstock LE , Johnson JA , Morris JG , Tacket CO , Kaper JB , Levine MM . Vibriocidal antibody responses in North American volunteers exposed to wild-type or vaccine Vibrio cholerae O139: specificity and relevance to immunity. Clin Diagn Lab Immunol. 1997;4:264-9. PMID:9144361
   PubMedGoogle Scholar
• Qadri F , Svennerholm AM , Shamsuzzaman S , Bhuiyan TR , Harris JB , Ghosh AN , Nair B , Weintraub A , Faruque SM , Ryan ET , et al. Reduction in capsular content and enhanced bacterial susceptibility to serum killing of Vibrio cholerae O139 associated with the 2002 cholera epidemic in Bangladesh. Infect Immun. 2005;73:6577-83. doi:10.1128/IAI.73.10.6577-6583.2005. PMID:16177333
   PubMed Web of Science ®Google Scholar
• World Health Organization . Cholera, 2012. Wkly Epidemiol Rec. 2013;88:321-34. PMID:23980290
   PubMedGoogle Scholar
• World Health Organization . Guidelines for the production and control of inactivated Oral Cholera vaccines. WHO Technical Report Series No 924., Annex 3 World Health Organization: Geneva 2004. www.who.int/biologicals/publications/trs/areas/vaccines/cholera/129-149.pdf. (accessed 27 March 2017)
   Google Scholar
• World Health Organization . The immunological basis for immunization series. Module 14: Cholera. http://apps.who.int/iris/bitstream/10665/44367/1/9789241599740_eng.pdf. (accessed 27 March 2017 )
   Google Scholar
• Uddin T , Aktar A , Xu P , Johnson RA , Rahman MA , Leung DT , Afrin S , Akter A , Alam MM , Rahman A , et al. Immune responses to O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 Ogawa in adult Bangladeshi recipients of an oral killed cholera vaccine and comparison to responses in patients with cholera. Am J Trop Med Hyg. 2014;90:873-81. doi:10.4269/ajtmh.13-0498. PMID:24686738
   PubMed Web of Science ®Google Scholar
• Ali M , Emch M , von Seidlein L , Yunus M , Sack DA , Rao M , Holmgren J , Clemens JD . Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis. Lancet. 2005;366:44-9. doi:10.1016/S0140-6736(05)66550-6. PMID:15993232
   PubMed Web of Science ®Google Scholar
• Qadri F , Wierzba TF , Ali M , Chowdhury F , Khan AI , Saha A , Khan IA , Asaduzzaman M , Akter A , Khan A , et al. Efficacy of a single-dose, inactivated oral cholera vaccine in Bangladesh. N Engl J Med. 2016;374:1723-32. doi:10.1056/NEJMoa1510330. PMID:27144848
   PubMed Web of Science ®Google Scholar
• Attridge SR , Johansson C , Trach DD , Qadri F , Svennerholm AM . Sensitive microplate assay for detection of bactericidal antibodies to Vibrio cholerae O139. Clin Diagn Lab Immunol. 2002;9:383-7. PMID:11874883
   PubMedGoogle Scholar
• Yang JS , Kim HJ , Yun C-H , Kang S-S , Im J , Kim H-S , Han SH . A semi-automated vibriocidal assay for improved measurement of cholera vaccine-induced immune responses. J Microbiol Methods. 2007;71:141-6. doi:10.1016/j.mimet.2007.08.009. PMID:17888533
   PubMed Web of Science ®Google Scholar
• Newcombe RG . Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med. 1998;17:857-72. doi:10.1002/(SICI)1097-0258(19980430)17:8%3c857::AID-SIM777%3e3.0.CO;2-E. PMID:9595616
   PubMed Web of Science ®Google Scholar